Quotient Ltd

Eysins, V8 · Founded 2012 · CIK 0001596946 · Biotech · Defunct

Somatic genomics platform for therapeutic development

quotient-tx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$92M
3 Form D · Nov 2017
107 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$27,066,500
Private capital raisedForm D · SEC$24,999,998
Private capital raisedForm D · SEC$40,159,214
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1937DeepSpace Storage Systems Inc.—$1.3M
1938Centrexion Therapeutics Corp—$189M
1939Aktis Oncology—$175M
1940Quotient Ltd—$92M
1941Myota, Inc.—$16M
1942AXIOMX INC——
1943Sparrow Pharmaceuticals—$73M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 13 related persons
  • Thomas BolognaDirector
  • Roland BoydExecutive Officer
  • Paul CowanDirector · Executive Officer
  • Edward FarrellExecutive Officer
  • Frederick HallsworthDirector
  • Christopher LindopExecutive Officer
  • Brian McDonoughDirector
  • Sarah O'ConnorDirector
  • Zubeen ShroffDirector
  • Jeremy StackawitzExecutive Officer
  • Stephen UngerExecutive Officer
  • Heino von ProndzynskiDirector
  • John WilkersonDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.